Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254
下一代成熟抑制剂 GSK3640254 的抗病毒疗效、安全性、耐受性和药代动力学 IIa 期概念验证评估
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciab1065
Spinner, Christoph D; Felizarta, Franco; Rizzardini, Giuliano; Philibert, Patrick; Mitha, Essack; Domingo, Pere; Stephan, Christoph J; DeGrosky, Michelle; Bainbridge, Veronica; Zhan, Joyce; Dumitrescu, Teodora Pene; Jeffrey, Jerry L; Xu, Jianfeng; Halliday, Fiona; Gan, Jianjun; Johnson, Mark; Gartland, Martin; Joshi, Samit R; Lataillade, Max